Key result
Early recurrence after pulsed-field ablation linked to ~3-fold higher risk of late AF recurrence.
Why the study?
Factors contributing to early recurrence after atrial fibrillation ablation with pulsed-field ablation are poorly understood, including their significance and prediction of late recurrence.
What factors are associated with early and late recurrence in patients undergoing pulsed-field ablation for atrial fibrillation?
Cohort (n=620)
Yes
What factors are associated with early and late recurrence in patients undergoing pulsed-field ablation for atrial fibrillation?
Odds Ratio: 3.26 (95% CI 2.01–5.29)
p-value: p=<0.0001
In patients undergoing pulsed-field ablation for atrial fibrillation, early recurrences significantly increase the risk of late recurrences, and larger left atrial volume index is associated with early recurrences.
BACKGROUND: Factors contributing to early recurrence after atrial fibrillation (AF) ablation, particularly with pulsed-field ablation (PFA), are poorly understood. PURPOSE: This study aimed to evaluate the significance of early recurrence and identify factors associated with its occurrence, focusing on predicting late recurrence in AF patients treated with PFA. METHODS: A total of 620 consecutive patients referred for their first paroxysmal or early persistent AF ablation underwent the procedure using the FARAPULSE PFA system (Boston Scientific) across 10 centers. Early recurrence was defined as atrial arrhythmia of > 30-s duration during the 3-month blanking period, and any recurrence beyond 3 months was considered as late recurrence. RESULTS: In total, 44 (7.1%) patients experienced early recurrences (median time to recurrence: 56 [22-75] days). At multivariate logistic analysis adjusted for baseline confounders larger left atrial volume index (LAVi) (1.03, 1.01-1.06, p = 0.0034) was significantly associated with early recurrences. In total, 113 (18.2%) patients experienced late recurrences. Factors independently associated with late recurrences included age (1.03, 1.01-1.05, p = 0.0077), sleep apnea (3.17, 1.73-5.81, p = 0.002), and early recurrences (3.26, 2.01-5.29, p < 0.0001). Early recurrences were associated to late recurrences also in paroxysmal AF only patients (40.0% vs. 16.9%, p < 0.0001). CONCLUSION: In this cohort of AF patients undergoing PFA, early recurrences significantly increased the risk of late recurrences, highlighting their potential as a predictive marker for long-term outcomes. Moreover, larger LAVi was associated with early recurrences. TRIAL REGISTRATION: Advanced TecHnologies For SuccEssful AblatioN of AF in Clinical Practice (ATHENA). URL: http://clinicaltrials.gov/. Identifier: NCT05617456.
No takes yet. Share an insight, caveat, or question.
Bisignani et al. (2025) conducted a cohort in Paroxysmal or early persistent atrial fibrillation (n=620). Early recurrence of atrial fibrillation vs. No early recurrence was evaluated on Late recurrence of atrial fibrillation (beyond 3 months) (OR 3.26, 95% CI 2.01-5.29, p=<0.0001). In patients undergoing pulsed-field ablation for atrial fibrillation, early recurrence was independently associated with an increased risk of late recurrence (OR 3.26; 95% CI 2.01-5.29; P<0.0001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: